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1039-59 Simvastatin Preserves tiyocardial Function by 
Enhancing Endothelial Nitric Oxide Production in Heart 
Failure 
Seena S. Abraham Juan C. Osorio, Jie Wang, James K. Liao, Shunichi Homma. Seema 
Mital. The New York-Presbyterian Hospital. New York, NY, Brigham 8 Women’s 
Hospital. Boston, MA 
Background: Endothelial nitric oxide synthase (ENOS) is reduced in heart failure (HF). 
Statins upregulate NO production independent of lipid-lowering. We evaluated the ability 
of simvastatin (Sim) lo reverse ventricular remodeling and dysfunction by restoring coro- 
nary NO production and NO mediated regulation of apoptosis. 
Methods: Five month old cardiomyopathic (CMP) hamsters were divided into 2 groups - 
Sim (n=5), and Untreated (n=5). Age-matched normal hamsters ware used as controls 
(n=6). Sim group received 20 “g/kg Sim daily by oral gavage for 6 weeks. Serial 2D 
echocardiograms were obtained at baseline and 2 week intervals. LV function and 
dimensions indexed lo body surface area were compared between groups. Myocardial 
apoptosis was evaluated by immunostaining and caspasa 3 activity assay. Myocardial 
ENOS expression was measured by Western blot and immunohistochemistry. 
Results: At baseline, CMP hamsters had lower LV shortening fraction (SF) compared to 
controls (17*2% vs.59+2%), higher LV diastolic volume (30*2 vs.6iO.5 ml/m*) and lower 
LV mass/volume ratio (0.5iO.02 vs. 0.72t0.02 “g/ml, p<O.OOl). Untreated CMP ham- 
sters demonstrated a progressive decrease in LVSF (12*1%, ~~0.05) and increase in LV 
volume from baseline (37*2 ml/m2, ~~0.05). The Sim group showed no deterioration in 
LV function (SF 18+.1%) or LV dilatation (LV volume, 26*2 “!I”‘, p<O.O5) compared to 
the untreated group. lmmunostainina revealed a hiaher percentaae of apoptotic nuclei in _ _ 
the HF group compared to controls (&096*0.04% vs.O.O32+0.02%, ~‘0.002). Caspase 3 
activity was lower in the Sim cornoared to the untreated orouo f1~0.001). lnhibitina -... , ” 
endogenous NO increased caspase 3 activity in the Sim (p=O.O5) but not in the untreated 
group. Myocardial ENOS staining revealed increased capillary density per 3 high power 
fields in the Sim (llOil2. pqO.05) compared to controls (47*9) and untreated hamsters 
(56ill). 
Conclusions: Sim administration preserves myocardial function, decreases LVremodel- 
ing and retards the progression of HF. This may be related to an increase in coronary 
microvasculature resulting in increased endothelial NO availability and reduced cardi- 
omyocyte apoptosis. 
1039-60 Pregnancy-Associated Cardiomyopathy: Early Versus 
Late Presentation 
Mohammed W. Akhter, Avraham Shotan, Afshan Hameed, Harpreet Singh, Salman 
Khan, Usman Ahsan, Muhammad T. Khan, Uri Elkayam, University of Southern 
California, Los Angeles, CA 
Background: Initial diagnostic criteria have limited Pregnancy associated cardiomyopa- 
thy (PACM) to last month of gestation or 5 months after delivery. These criteria however, 
were established 4 decades ago and may have been limited by inferior diagnostic capa- 
bilities and small number of patients. We have therefore reexamined the timing of symp- 
toms onset as well as diagnosis I” 137 patients (pts) recently diagnosed with PACM. 
Methods: We reviewed records of 137 pts with PACM with the following criteria: 1. 
Development of heart failure (HF) during pregnancy or first 6 months postpartum (PP), 2. 
Absence of identifiable cause of HF, 3. Depressed ejection fraction (EF)< 40 %. 
Results: Timing of symptoms onset and diagnosis were as follows: 
TIME ~27 28-36 37-40 1 MONTH 2-6 MONTHS 
WEEKS WEEKS WEEKS PP PP 
Symptoms 8% 21% 6% 58% 7% 
onset 
Diagnosis 3% 13% 6% 62% 16% 
PACM was diagnosed early (~37 weeks) I” 20 pts and late c> 37 weeks) in 102 pts. 
There was no difference in age (30 f 6 vs 31 * 6 years, p=O.74), gravity (2.5 5 6.3 vs 2.7 
* 2.3, p=O.65) or EF both at time of diagnosis (32 * 11% YS 31 + 12%, p=O.93) and follow 
up of 26 months (44 * 16% vs 45 + 15%, p=O.53) between the 2 groups. 
Conclusions Although PACM mostly presents during the first month PP, almost 30% of 
cases present during the 2nd and 3rd trimester prior to last gestational month. Increased 
awareness of early presentation of PACM is important to allow early diagnosis and 
appropriate care of this potentially life threatening condition. 
ABSTRACTS - Cardiac Function and Heart Failure 151A 
1039-61 Predictors of In-Patient Mortality Following Emergency 
Heart Failure Hospitalization 
Colin Berry, Michael Brett, Karen Stevenson, John Norrie, John McMurray, University of 
Glasgow, Glasgow, United Kingdom 
Introduction: Much of the information on heart failure (HF) has been derived from clinical 
trials. We sought to determine the characteristics which may be associated with suwival 
in ‘real-life’, hospitalized, HF patients. 
Methods: We examined the clinical characteristics and predictors of in-hospital case- 
fatality in 547 consecutive emergency admissions with HF to one acute urban University 
hospital over 1 year period. 
F&sub: Average age was 72 (SD 13) years, 49% were male and 476 patients (87%) sur- 
vived lo discharge. 414 (75%) had an echocardiogram. of whom 133 (32%) had pre- 
served left ventricular systolic function (LVSF). Mean hemoglobin (Hb) concentration was 
12.5*2.1 g/dL in males and 12.Okl.9 g/dL in females. 52% of man and 37% of women 
were anemic (normal range man Hb 13 - 18 g/dL, women Hb 11.5 - 16.5g/dL). The % of 
man with Hb < 13, 12, 11, 10 g/dl was 16. 14. 10 and 12% respectively (women, % Hb < 
11.4, 10.4, 9.4 and 8.4 g/dl was 21, 8, 6 and 3%). Mean white cell count (WCC) was 9.24 
x 109/L (4-l 1 x 109/L). and 22% of patients had low WCC. Mean lymphocyte count (LC) 
wasl.6 x 109/L and 58% of patients had a low LC. In-patient case fatality rate tended to 
be higher for patients with impaired LVSF, compared to preserved LVSF (13% YS 8%; 
P=O.OG).The probability of being alive at discharge was increased by treatment with an 
ACE inhibitor (odds ratio (OR) 1 .l, 95% Cl 1.0-1.2: P=O.O2) or an HMG CoA reductase 
inhibitor (OR 1.1, Cl 1.0-1.2; P=O.O04). A higher Hb concentration was also positively 
associated with survival (OR 1.03 per g/dL, Cl 1.0-l .05; P~0.02). Factors associated with 
an increased risk of death during admission were the presence of renal dysfunction (OR 
1.2, Cl 1 .1-l .3: P=O.Ol) and ischemic chest pain (OR 1.2, Cl 1.1-l .3; P= 0.001). Diabe- 
tes (OR 1.1; Cl 0.97-l .2; P=O.2) and an elevated C-reactive protein concentration (OR 
1.01; Cl 1 .OO-1.02; P=O.O8) tended to be associated with an increased risk of death. 
Conclusion: Both low WCCILC (by increasing the risk of infection) and low Hb may con- 
tribute to HF decompensation. Statin therapy and Hb concentration may be two new 
markers of shorl term prognosis. The potentially protective effects of a higher Hb and sta- 
tin therapy merit prospective investigation in HF. 
1039-62 Impact of Peripheral Endothelial Vasomotor Function 
on Exercise Capacitv and Adhesion Molecules in 
ldiopathlc Dilated Cardiomyopathy 
Barbara M. Richariz, Friedhelm Kuethe, Hans R. Figulla, Gerald S. Werner, Friedrich- 
Schiller-University Jena, Jena. Germany 
Background: Exercise tolerance- which has been linked to impaired blood perfusion of 
skeletal muscles _ varies significantly between patients with hearl failure. Recent studies 
have shown endothelial dysfunction of peripheral resistance arteries and an impaired 
flow-dependent-dilation (FDD) of conduit vessels. This study was designed to determine 
the degree of impaired FDD on exercise capacity and endothelial activation. 
Methods In 38 patients with idiopathic dilated cardiomyopathy (IDC) longitudinal radial 
artery images were obtained with a high-resolution (10 MHz) vascular transducer. FDD 
was determined by maximal radial diameter after exactly 60 s of reactive hyperemia com- 
pared to baseline vessel diameter. FDD was defined as a change > 5%. Serum concen- 
trations of ICAM- and VCAM-1 were analyzed by ELISA. The severity of heart failure 
was assessed in accordance to NYHA-classification. hemodynamic parameters (pulmo- 
nary capillary wedge pressure. I& ventricular ejection fraction). and peak oxygen con- 
sumption. 
Results: Two distinct patterns of peripheral FDD could be distinguished: In 21 patients 
(group 1, 55%) radial artery dilates in response to reactive hyperemia, whereas in 17 
patients (group 2, 45%) impaired FDD was observed implicating endothelial dysfunction 
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Conclusions: The severity of heart failure in IDC and thus exercise intolerance is closely 
linked to peripheral endothelium vasomotor dysfunction and accompanied by endothelial 
activation. 
1039-63 Clonal T-Cell Composition Detected by Family Specific 
Polymerase Chain Reaction of the T-Cell Receptor Beta 
Chain Is Exclusively Present in Dilated Cardiomyopathy 
Michel Noutsias Jan H. Blohm, Chalid Assaf, Nadine Bigdeli-lssazadeh, Michael 
Hummel, Rabat S. Warraich, Magdi H. Yacoub, Harald Stein. Heinz P. Schultheiss, 
Matthias Pauschinger, UKBF, Free University, Berlin, Germany, NHLI, Harefield 
Hospital, Middlesex, United Kingdom 
Background: Autoimmunity, resulting from molecular mimicry between viral and cryptic 
cardiac antigens. is postulated for the pathogenesis of dilated cardiomyopathy (DCM). 
Autoimmunity directed against distinct antigens evokes expansion of specific T-cell 
clones infiltrating the target tissue. This phenomenon leads to a clonal predominance of 
T-cells harboring an identical rearranged T-cell receptor gene (TCR), which can be reli- 
ably identified by family specific PCR for the WN-DP-N-Jpregion of the TCR gene in 
combination with high-resolution GeneScan-analysis. 
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Methods: DNA extracted from explanted DCM hearts (n=l7, 1 female; 49+/-13 years; 
LVEF: la+/-5%) were investigated for clonality of the TCR-P-gene. Non-DCM-hearts 
(ischaemic cardiomyopathy: n=2, valvular heart disease: n=3, donor hearts: n=3) served 
as Cantrob. The TCR-PCR-products analyzed by high-resolution fragment analysis 
(GeneScan), displayed a Gaussian-like distribution profiles I” polyclonal and single dom- 
inant peaks ln monoclonal T-cell populations. Clonal TCR-P PCR-products were directly 
sequenced. 
Results: The GeneScan analysis of the TCR-P PCR-products demonstrated a clonal T- 
cell population in n=9117 (53%) of the DCM hearts. In contrast, exclusively polyclonal 
composition of the TCR-P PCR-products were obtained from the non-DCM hearts. 
Sequence analysis of the clonal TCR-P PCR-products from the n=9 DCM hearts deter- 
mined Vpl9.01 in n=6 cases (67%), and VP-1 .Ol, Vp6-3.01 and VplO-3.04 in each of 
the remaining cases. 
Conclusion: Clonal T-cell composition is exclusively present in DCM, as detected by 
PCR and GeneScan analysis of the TCR-P rearrangement. This phenomenon indicates a 
clonal T-cell proliferation due to specific antigen, which confirms the autoimmune hypoth- 
esis of DCM. Our results, demonstrating a clear predominance of Vpl9.01 T-cell clones 
in DCM, warrant the molecular analysis of the respective immunogenic sequence and 
eventually a TCR-based immunotherapy in DCM (e.g. with DNA vaccines). 
1039-64 Prenatal Naltrexone Exposure Adversely Alters 
Postnatal Cardiac Development: A Model for Dilated 
Cardiomyopathy 
Kern, L. Rosen, James D. Wylie, Stephen E. Cyran. Ian S. Zagon, Patricia J. 
McLaughlin, The Milton S. Hershey Medical Center, Penn State College of Medicine, 
Hershey, PA 
Background: Opiod Growth Factor (OGF) is an Inhibitory pentapeptide that interacts 
with its receptor (OGFr) to target cell proliferabon and DNA synthesis. Previous studies 
have shown that chrome disruption of the OGF/OGFr interaction by naltrexone (NTX) 
had a stimulatory effect on myocardial development. We hypothesized that in utero expo- 
sure to NTX alters postnatal cardiac function. 
Methods: Time-mated Sprague-Da&y rats received injections of 30 mglkg of NTX or 
0.3 ml saline twice a day throughout gestation. Offspring wets cross-fostered to non- 
injected, lactating females. Left ventricle (LV) size and function were evaluated by 
echocardiography in postnatal day (PD) 35, 55 and 110 NTX exposed and control rats. 
Six to eight male and female offspring of each group were studied for LV end diastolic 
dimension, LV thickness, shortening fraction (SF) and heart rate. 
Results: PD 35 male and female and PD55 female offspring exposed to NTX had signif- 
icantly dilated left ventricles compared to controls (p<O.Ol). PDllO NTX exposed rats 
had increased thickness of the LV free wall (pcO.O5), but no changes occurred earlier. SF 
was significantly decreased (p.zO.01) relative to controls in all NTX exposed rats at all 
ages studied. SF decreases in the NTX group ranged from 12-19%. Heart rate was sig- 
nificantly decreased in the NTX exposed rats compared to controls (~~0.05). 
Conclusions: NTX exposed offspring demonstrated significant changes in ventricular 
size, systolic function and heart rate. The NTX exposed rats had dilated left ventricles at 
earlier ages .The NTX rats had decreased ventricular systolic function and decreased 
heari rates at all ages studied. This data suggests that in utero blockade of OGF activity 
by NTX leads to significant ventricular dilation and impared systolic function. This infor- 
mation may provide a unique model that will allow for further study of dilated cardiomyo- 
pathies. 
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1039-65 Oscillatory Pattern of Respiratory Gas Exchange During 
Cardiopulmonary Exercise Test in Chronic Heart 
Failure: Clinical and Functional Correlates 
Giovanna Briahetti, Lorenzo Franceschini, Luisa Zanolla, Mariantonietta Cicoira, Andrea 
Rossi, Giorgio Golia, Piero Zardini, Universita’degli Studi di Verona, Verona. Italy 
Background: In chronic heart failure (CHF), periodic oscillations in 0, consumption 
(Vq). CO, production (VCOJ and ventilation may appear in the Initial phases of car- 
diopulmonary exercise test, with controversial clinical significance. AIM: To characterize, 
in clinical and functional terms, CHF patients with an oscillatory gas kinetics during car- 
diopulmonary test. Methods: We evaluated 195 clinically stable CHF outpatients (171 
males; mean age 62.3+9 years), with an echocardiogram and a cardiopulmonary, symp- 
tom-limited, exercise test. Results: Twenty-SIX patients had an oscillatory pattern of VQ 
and VCO, in the initial phases of exercise (group 1). while 169 did not (group 2). Mean 
age was 67.1*6.5 years in group 1 and 61.5k8.9 in group 2 (p=O.O03). Ejection fraction 
(EF) was 29+8% versus 34+7% respectively (p=O.O09). NO differences existed in sex. 
etiology, NYHA class, cardiac rhythm and mean peak respiratory quotient (>I .I 1 in both 
groups). Patients with an oscillatory pattern had a significantly lower peak VO, (13.2+3.4 
mUKg/mm versus 16.8*4.8; p=O.O003). a higher ventilatory equivalent response (VEI 
VC0$.lope)(4l.O+6.2 versus 36.226.1, respectively; p=O.O003), a shorter exercise dura- 
tion time (7.8+2.0 minutes versus 9.6e2.4; p=O.O004) and a lower peak systolic blood 
pressure (158.1*23.6 mmHg versus 176.9i31.8; p=O.O04). At univariate analysis, peak 
VO? correlated with age, sex, NYHA class, EF, peak systolic blood pressure and oscilla- 
toly pattern. In a multivariate analysis model comprising all the univariate determinants of 
peak Vq, the oscillatory kinetics predicted peak VO, independently of the other vari- 
ables (p=O.OOS). At univ.&ate analysis, VE/VCO$lope correlated with age, sex, NYHA 
class, EF, peak systolic blood pressure and oscillatory pattern. In a multivariate model 
analyzing the VENCO,slope and all these covariates, the oscillatory kinetics was an 
independent predictor of the ventilatory equivalent response (p=O.O17). Conclusions In 
CHF, an oscillatory pattern of respiratory gas exchange during cardiopulmonary test is 
associated with a significantly warse exercise tolerance, independently of other known 
determinants of functional capacity 
1039-66 Long-Term Treatment With Selective Endothelin ETA 
Receptor Antagonist Suppressed NADPH Diaphorase 
Activity and Improved Left Ventricular Diastolic 
Function in Cardiomyopathy 
Tetsuva Havashi, Masahlro Nishida. Minoru Yoshiyama. Yoshikatsu Okada, Sakiko 
Inamoto, Nobuaki Okuda, Yasuo Matsumura, Hiroshi Mod, Yasushi Kitaura, Osaka 
Medical College, Takatsuki, Japan, Osaka City University, Osaka, Japan 
Background: Endothelin-1 (ET-l) receptor antagonist is expected to improve prognosis 
of patients with heart failure, but the effect of ETA and ETB receptor antagonist on car- 
diac function and structure is still controversial. We assessed the hypothesis that long- 
term treatment with ETA receptor antagonist could reduce inducible nitric oxide synthase 
(INOS) in failing heart and improve the cardiac dysfunction in the model of dilated cardi- 
omyopathy. Methods: A selective ETA receptor antagonist ABT-627 (ETa; 10 mgikglday) 
or a selective ETB receptor antagonist A-192621 (ETb: 15 mglk g/day) was given in 22- 
week-old J-2-N cardiomyopathic (Nk) hamsters, representing severe heart failure, for 2 
months. ET-l content and NADPH diaphorase activity in left ventricular (LV) myocardium 
were studled by electron microscopy. Results: Though ETb showed inotropic and chro- 
notropic effect on cardiac function, degeneration of cardiomyocytes remarkably pro- 
gressed. ETa efficiently preserved the LV diastolic function and tissue damage, 
furthermore suppressed the NADPH diaphorase activity representing iNOS and ET-1 
content in LV. Conclusions: Both ETa and ETb are potent to improve cardiac function. 
However, only ETa could reduce iNOS and ET-1 content, and also preserve the fine 
structure of LV myocardium in cardiomyopathy. 
Control Nk+vehicle Nk+ETa Nk+ETb 
(n=10) (ll=lO) (n=9) (ll=lO) 
Heart Rate (bpm) 392*9 364+18 367+20 458+9^# 
LV pressure (mmHg) 152~7 109*3* 103+3 130*2’# 
Ejection Fraction (%) 40+4 22*1* 24+2 35+3?# 
Dct (cm/s?) 1425*108 2517*190* 1886+105# 1908+178# 
Cardiac@ Diameter 17.8ztO.l 26.1+0.6’ 18.5+0.5# 27.3kO.7’ 
(urn) 
Values are Mean&EM. Dct; deceleration slope. *pcO.O5 Versus Control. #p,O.O5 
Versus Nk+vehicle. 
1039-67 Novel Lamin A/C Mutations in Idiopathic Dilated 
Cardiomyopathy and/or Conduction Disease 
Peter van Tint&n, Hilaa Katerbera. Ludolf Boven. Ans Wiesfeld. Arthur A. Wilde, Irene 
M. van Langen, Tom Fiossenbacker, Maarien P. van den Berq Dirk J. van Veldhuisen. 
Charles H. Buvs. Robert Hofstra. Yvonne Vos. Universitv Hospital Groninaen. , 
Groningen, The Netherlands, Academic Medical Centre, Amsterdam, The Netherlands 
Background Idiopathic dilated cardiomyopathy (DCM) is familial in up to 30% of cases. 
Recent studies have shown that mutations in the lamin A!C (LMNA) gene can cause 
dilated cardiomyopathy with or without preceding cardiac conduction disease (CCD). 
Mutations in this gene are identified in up to 33% of cases with DCM+CCD. Our purpose 
was to assess to what extent mutations in the LMNA gene are responsible for DCM ci- 
CCD in our population and to test the hypothesis that LMNA mutations can be identified 
in patients with (still) pure CCD because CCD can precede DCM by 10 to 20 years. 
Methods we studied the LMNA gene in 27 index cases with a cardiac phenotype but with- 
out overt signs of generalised myopathy using a PCRlDGGEisequencing analysis. 10 
Index patients had DCM+CCD, 14 had “pure” DCM, 3 had CCD. Patients were subclassi- 
fied according to family history and additional medical information from family members 
(see table). 
Results (see table)Novel mutations were identified in 1 family with pure DCM (1512. 
1513insAG) and in a patient with DCM+CCD and a positive family history (IVS7+1 G>A). 
Mutations described before were identified in 1 large family with DCM+CCD (AsnlSbLys) 
and 1 family with CCD (Arg225X). 
Conclusions LMNA mutations were identified in families with DCM +CCD or pure DCM 
but also in a family with isolated CCD. LMNA mutations can be identified in patients or 
families with (still) an isolated CCD phenotype because CCD can precede DCM by up to 
20 years. Two of the mutations identified were not described before. 
phenotype/total no category no. patients mutation 
DCM+CCD (n=lO) proven familial 5 Asnl95Lys 
pas. family history 2 IVS7+lG>A(novel) 
sporadic 3 
pure DCM (n=l4) proven familial 11 1512.1513insAG(novel) 
pas. family history 1 
sporadic 2 
CCD (n=3) familial 3 Arg225X 
total 27 4 
